Neurolutions

Neurolutions is a company focused on developing innovative rehabilitation technologies for stroke recovery. Their flagship product, IpsiHand, is the first FDA-cleared non-invasive brain-computer interface system designed to help stroke survivors regain movement in their arms and hands. By using EEG technology to detect brain signals associated with the intention to move, IpsiHand enables users to improve their hand function through targeted at-home therapy. Neurolutions aims to revolutionize stroke treatment and rehabilitation, offering hope to patients who have reached a plateau in their recovery. They support insurance coverage options and provide resources for both patients and clinicians seeking to enhance rehabilitation outcomes.